Tyra Biosciences, Inc. (TYRA)
NASDAQ
Market Cap
$829.1M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
781 of 809
Rank in Industry
428 of 445
Largest Insider Buys in Sector
TYRA Stock Price History Chart
TYRA Stock Performance
About Tyra Biosciences, Inc.
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.
Insider Activity of Tyra Biosciences, Inc.
Over the last 12 months, insiders at Tyra Biosciences, Inc. have bought $0 and sold $5.62M worth of Tyra Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Tyra Biosciences, Inc. have bought $73.28M and sold $8.16M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 250,000 shares for transaction amount of $3.28M was made by Boxer Capital, LLC (10 percent owner) on 2021‑12‑17.
List of Insider Buy and Sell Transactions, Tyra Biosciences, Inc.
| 2024-06-10 | Sale | Bensen Daniel | Chief Operating Officer | 3,502 0.0067% | $20.00 | $70,045 | -12.63% | |
| 2024-06-07 | Sale | Bensen Daniel | Chief Operating Officer | 200 0.0004% | $20.00 | $4,000 | -10.26% | |
| 2024-03-11 | Sale | Bensen Daniel | Chief Operating Officer | 200 0.0005% | $20.00 | $4,000 | -11.97% | |
| 2024-03-07 | Sale | Bensen Daniel | Chief Operating Officer | 68 0.0002% | $20.00 | $1,360 | -11.70% | |
| 2024-03-06 | Sale | Bensen Daniel | Chief Operating Officer | 1,733 0.0041% | $20.09 | $34,819 | -12.47% | |
| 2024-03-05 | Sale | Bensen Daniel | Chief Operating Officer | 1,189 0.0028% | $20.02 | $23,802 | -10.77% | |
| 2024-03-04 | Sale | Bensen Daniel | Chief Operating Officer | 5,063 0.0119% | $20.08 | $101,654 | -13.32% | |
| 2024-03-01 | Sale | Bensen Daniel | Chief Operating Officer | 2,900 0.0068% | $20.04 | $58,112 | -12.73% | |
| 2024-02-29 | Sale | Bensen Daniel | Chief Operating Officer | 2,050 0.004% | $20.00 | $41,003 | -13.07% | |
| 2024-02-28 | Sale | Bensen Daniel | Chief Operating Officer | 5,849 0.0113% | $20.13 | $117,729 | -12.71% | |
| 2024-02-27 | Sale | Bensen Daniel | Chief Operating Officer | 745 0.0015% | $20.00 | $14,900 | -11.39% | |
| 2024-02-12 | Sale | Bensen Daniel | Chief Operating Officer | 1,501 0.0036% | $20.00 | $30,020 | -8.41% | |
| 2024-02-07 | Sale | Bensen Daniel | Chief Operating Officer | 9,587 0.0297% | $18.09 | $173,466 | -1.06% | |
| 2024-02-06 | Sale | Bensen Daniel | Chief Operating Officer | 15,413 0.0477% | $18.09 | $278,827 | -1.03% | |
| 2024-02-05 | Sale | Harris Todd | President and CEO | 13,817 0.0401% | $16.97 | $234,430 | +3.30% | |
| 2024-02-02 | Sale | Harris Todd | President and CEO | 86,183 0.2433% | $16.50 | $1.42M | +5.92% | |
| 2024-02-02 | Sale | Bensen Daniel | Chief Operating Officer | 75,393 0.2107% | $16.33 | $1.23M | +5.92% | |
| 2023-07-21 | Sale | Bensen Daniel | Chief Operating Officer | 3,900 0.0092% | $16.01 | $62,428 | -7.52% | |
| 2023-07-19 | Sale | Bensen Daniel | Chief Operating Officer | 207 0.0005% | $16.07 | $3,328 | +0.68% | |
| 2023-07-17 | Sale | Bensen Daniel | Chief Operating Officer | 1,900 0.0045% | $16.03 | $30,464 | -6.95% |
Insider Historical Profitability
<0.0001%
| Harris Todd | President and CEO | 1502697 3.5004% | $15.80 | 0 | 19 | |
| Bensen Daniel | Chief Operating Officer | 427981 1.0552% | $15.80 | 0 | 41 | |
| Boxer Capital, LLC | 10 percent owner | 6448359 15.021% | $15.80 | 2 | 0 | <0.0001% |
| RA CAPITAL MANAGEMENT, L.P. | 5297120 12.3393% | $15.80 | 1 | 0 | <0.0001% | |
| MORE ROBERT J | director | 4080296 9.5048% | $15.80 | 1 | 0 | <0.0001% |
| Alta Partners NextGen Fund II Management, LLC | 10 percent owner | 4080296 9.5048% | $15.80 | 1 | 0 | <0.0001% |
| Cormorant Asset Management, LP | 1069932 2.4923% | $15.80 | 1 | 0 | <0.0001% | |
| MVA Investors, LLC | 10 percent owner | 22527 0.0525% | $15.80 | 0 | 2 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| RA Capital Management, L.P. | $170.83M | 19.83 | 10.42M | +43.95% | +$52.15M | 0.17 | |
| Boxer Capital, LLC | $105.75M | 12.27 | 6.45M | 0% | +$0 | 5.29 | |
| Bvf Inc Il | $76.44M | 8.87 | 4.66M | +70.14% | +$31.51M | 0.56 | |
| Canaan Partners Xi Llc | $72.32M | 8.39 | 4.41M | 0% | +$0 | 79.77 | |
| Nextech Invest | $66.52M | 7.72 | 4.06M | +61.04% | +$25.21M | 10.85 | |
| Fidelity Investments | $65.23M | 7.57 | 3.98M | +43.65% | +$19.82M | <0.01 | |
| Tcg Crossover Management Llc | $32.62M | 3.79 | 1.99M | 0% | +$0 | 0.05 | |
| Fairmount Funds Management LLC | $22.85M | 2.65 | 1.39M | 0% | +$0 | 2.49 | |
| BlackRock | $17.13M | 1.99 | 1.04M | +8.21% | +$1.3M | <0.0001 | |
| 5Am Venture Management Llc | $15.4M | 1.79 | 939,298 | +69.25% | +$6.3M | 1.04 | |
| The Vanguard Group | $14.76M | 1.71 | 899,800 | +18.56% | +$2.31M | <0.0001 | |
| Frazier Life Sciences Management L P | $13.65M | 1.58 | 832,220 | -18.92% | -$3.18M | 0.7 | |
| OrbiMed | $12.61M | 1.46 | 768,638 | New | +$12.61M | 0.26 | |
| Perceptive Advisors | $10.97M | 1.27 | 669,159 | +85.88% | +$5.07M | 0.01 | |
| Sio Capital Management LLC | $8.79M | 1.02 | 535,741 | New | +$8.79M | 3.11 | |
| Kynam Capital Management Lp | $8.45M | 0.98 | 515,190 | +51.44% | +$2.87M | 0.11 | |
| Geode Capital Management | $6.84M | 0.79 | 416,808 | +24.99% | +$1.37M | <0.01 | |
| JPMorgan Chase | $6.24M | 0.72 | 380,597 | -5.25% | -$346,187.61 | <0.01 | |
| State Street | $4.79M | 0.56 | 292,234 | +10.13% | +$440,832.04 | <0.0001 | |
| ExodusPoint Capital Management, LP | $4.46M | 0.52 | 272,150 | New | +$4.46M | 0.06 | |
| Driehaus Capital Management LLC | $3.34M | 0.39 | 203,709 | 0% | +$0 | 0.03 | |
| Northern Trust | $2.57M | 0.3 | 156,472 | +2.77% | +$69,240.80 | <0.0001 | |
| Nicholas Investment Partners, L.P. | $2.51M | 0.29 | 152,968 | New | +$2.51M | 0.28 | |
| Charles Schwab | $2.5M | 0.29 | 152,212 | +37.7% | +$683,470.06 | <0.01 | |
| Wellington Management Company | $1.67M | 0.19 | 101,788 | -0.63% | -$10,627.20 | <0.0001 | |
| Oppenheimer Holdings | $977,046.00 | 0.11 | 59,576 | New | +$977,046.00 | 0.01 | |
| Renaissance Technologies | $892,000.00 | 0.1 | 54,400 | New | +$892,000.00 | <0.01 | |
| Victory Capital Management Inc | $788,676.00 | 0.09 | 48,090 | -4.24% | -$34,932.00 | <0.01 | |
| BNY Mellon | $717,254.00 | 0.08 | 43,735 | +4.27% | +$29,356.00 | <0.0001 | |
| Two Sigma | $684,569.00 | 0.08 | 41,742 | New | +$684,569.00 | <0.01 | |
| Morgan Stanley | $577,887.00 | 0.07 | 35,237 | -1.21% | -$7,068.40 | <0.0001 | |
| Bank of America | $541,725.00 | 0.06 | 33,032 | +49.34% | +$178,989.67 | <0.0001 | |
| New York State Common Retirement Fund | $527,000.00 | 0.06 | 32,149 | +697.54% | +$460,922.14 | <0.01 | |
| Nuveen | $421,693.00 | 0.05 | 25,713 | 0% | +$0 | <0.0001 | |
| American Century Investments | $408,967.00 | 0.05 | 24,937 | +129.2% | +$230,534.91 | <0.0001 | |
| RhumbLine Advisers | $344,362.00 | 0.04 | 20,998 | -1.57% | -$5,477.52 | <0.0001 | |
| Legato Capital Management Llc | $332,248.00 | 0.04 | 20,259 | New | +$332,248.00 | 0.04 | |
| Marshall Wace | $322,145.00 | 0.04 | 19,643 | -34.53% | -$169,871.10 | <0.0001 | |
| Citadel Advisors LLC | $275,340.00 | 0.03 | 16,789 | New | +$275,340.00 | <0.0001 | |
| Walleye Capital | $276,947.00 | 0.03 | 16,887 | New | +$276,947.00 | <0.01 | |
| Exchange Traded Concepts, LLC | $263,269.00 | 0.03 | 16,053 | +68.43% | +$106,960.72 | 0.01 | |
| Fishman Jay A Ltd Mi | $246,000.00 | 0.03 | 15,000 | New | +$246,000.00 | 0.03 | |
| Jump Financial Llc | $248,607.00 | 0.03 | 15,159 | New | +$248,607.00 | <0.01 | |
| UBS | $232,421.00 | 0.03 | 14,172 | +184.75% | +$150,798.13 | <0.0001 | |
| Goldman Sachs | $230,863.00 | 0.03 | 14,077 | New | +$230,863.00 | <0.0001 | |
| Hudson Bay Capital Management LP | $218,399.00 | 0.03 | 13,317 | New | +$218,399.00 | <0.01 | |
| PDT Partners | $199,654.00 | 0.02 | 12,174 | New | +$199,654.00 | 0.02 | |
| Baker Bros Advisors LP | $173,955.00 | 0.02 | 10,607 | 0% | +$0 | <0.01 | |
| Dimensional Fund Advisors | $176,300.00 | 0.02 | 10,750 | +1.33% | +$2,312.40 | <0.0001 | |
| Barclays | $161,000.00 | 0.02 | 9,850 | -48.77% | -$153,268.73 | <0.0001 |